Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-interventional Observational Study to Characterize Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine

NCT06087627 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT06087627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06087627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-interventional Observational Study to Characterize Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
Lead sponsor
Sanofi
Phase
Observational
Overall status
Active, not recruiting
Start date
December 27, 2023
Completion date
December 31, 2027
Enrollment
110 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

prurigo nodularis